Do analysts prefer AGPU or RVP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Predictive Oncology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Does the media prefer AGPU or RVP?

In the previous week, Predictive Oncology and Predictive Oncology both had 1 articles in the media. Predictive Oncology's average media sentiment score of 0.00 equaled Retractable Technologies'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Predictive Oncology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Retractable Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer RVP or LNSR?

LENSAR has a consensus target price of $10.00, suggesting a potential upside of 56.25%. Given LENSAR's stronger consensus rating and higher probable upside, analysts clearly believe LENSAR is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 LENSAR 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts rate RVP or NYXH?

Nyxoah has a consensus price target of $7.00, indicating a potential upside of 306.98%. Given Nyxoah's stronger consensus rating and higher probable upside, analysts plainly believe Nyxoah is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Nyxoah 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Does the media favor RVP or NYXH?

In the previous week, Nyxoah had 2 more articles in the media than Retractable Technologies. MarketBeat recorded 3 mentions for Nyxoah and 1 mentions for Retractable Technologies. Retractable Technologies' average media sentiment score of 0.00 equaled Nyxoah'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Retractable Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nyxoah 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer RVP or ECOR?

electroCore has a consensus price target of $18.00, suggesting a potential upside of 105.25%. Given electroCore's stronger consensus rating and higher probable upside, analysts plainly believe electroCore is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 electroCore 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate RVP or LUNG?

Pulmonx has a consensus target price of $5.58, suggesting a potential upside of 301.68%. Given Pulmonx's stronger consensus rating and higher probable upside, analysts plainly believe Pulmonx is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Pulmonx 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43

Retractable Technologies (RVP) Competitors

$0.73 0.00 (0.00%)

Closing price 07/2/2026 03:59 PM Eastern

Extended Trading

$0.73 0.00 (-0.15%)

As of 07/2/2026 04:10 PM Eastern

Compare

RVP vs. AGPU, LNSR, NYXH, ECOR, and LUNG

Should you buy Retractable Technologies stock or one of its competitors? MarketBeat compares Retractable Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Retractable Technologies include Predictive Oncology (AGPU), LENSAR (LNSR), Nyxoah (NYXH), electroCore (ECOR), and Pulmonx (LUNG). These companies are all part of the "medical equipment" industry.

How does Retractable Technologies compare to Predictive Oncology?

Predictive Oncology (NASDAQ:AGPU) and Retractable Technologies (NYSE:RVP) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations.

Retractable Technologies has a net margin of -41.11% compared to Predictive Oncology's net margin of -470,383.31%. Retractable Technologies' return on equity of -17.15% beat Predictive Oncology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Predictive Oncology	-470,383.31%	-7,363.67%	-626.32%
Retractable Technologies	-41.11%	-17.15%	-9.33%

Retractable Technologies has higher revenue and earnings than Predictive Oncology. Retractable Technologies is trading at a lower price-to-earnings ratio than Predictive Oncology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Predictive Oncology	$50.29K	1,523.29	-$233.10M	-$8.18	N/A
Retractable Technologies	$37.15M	0.59	-$7.01M	-$0.21	N/A

Predictive Oncology has a beta of 3.43, indicating that its share price is 243% more volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.22, indicating that its share price is 22% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Predictive Oncology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

9.0% of Predictive Oncology shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 1.2% of Predictive Oncology shares are held by insiders. Comparatively, 59.5% of Retractable Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Predictive Oncology and Predictive Oncology both had 1 articles in the media. Predictive Oncology's average media sentiment score of 0.00 equaled Retractable Technologies'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Predictive Oncology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Retractable Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Retractable Technologies beats Predictive Oncology on 7 of the 12 factors compared between the two stocks.

How does Retractable Technologies compare to LENSAR?

Retractable Technologies (NYSE:RVP) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

Retractable Technologies has a beta of 1.22, indicating that its share price is 22% more volatile than the broader market. Comparatively, LENSAR has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market.

In the previous week, Retractable Technologies had 1 more articles in the media than LENSAR. MarketBeat recorded 1 mentions for Retractable Technologies and 0 mentions for LENSAR. Retractable Technologies' average media sentiment score of 0.00 equaled LENSAR'saverage media sentiment score.

Company	Overall Sentiment
Retractable Technologies	Neutral
LENSAR	Neutral

LENSAR has a consensus target price of $10.00, suggesting a potential upside of 56.25%. Given LENSAR's stronger consensus rating and higher probable upside, analysts clearly believe LENSAR is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
LENSAR	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 40.2% of LENSAR shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by company insiders. Comparatively, 65.8% of LENSAR shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Retractable Technologies has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.59	-$7.01M	-$0.21	N/A
LENSAR	$58.44M	1.34	-$34.28M	-$0.58	N/A

LENSAR has a net margin of 50.94% compared to Retractable Technologies' net margin of -41.11%. Retractable Technologies' return on equity of -17.15% beat LENSAR's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
LENSAR	50.94%	-183.19%	42.26%

Summary

LENSAR beats Retractable Technologies on 9 of the 15 factors compared between the two stocks.

How does Retractable Technologies compare to Nyxoah?

Retractable Technologies (NYSE:RVP) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends.

Retractable Technologies has higher revenue and earnings than Nyxoah. Retractable Technologies is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.59	-$7.01M	-$0.21	N/A
Nyxoah	$11.33M	5.88	-$101.92M	-$2.48	N/A

Retractable Technologies has a net margin of -41.11% compared to Nyxoah's net margin of -543.21%. Retractable Technologies' return on equity of -17.15% beat Nyxoah's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Nyxoah	-543.21%	-163.73%	-80.24%

7.6% of Retractable Technologies shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by insiders. Comparatively, 17.1% of Nyxoah shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Nyxoah had 2 more articles in the media than Retractable Technologies. MarketBeat recorded 3 mentions for Nyxoah and 1 mentions for Retractable Technologies. Retractable Technologies' average media sentiment score of 0.00 equaled Nyxoah'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Retractable Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nyxoah	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Retractable Technologies has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market. Comparatively, Nyxoah has a beta of 1.61, suggesting that its share price is 61% more volatile than the broader market.

Nyxoah has a consensus price target of $7.00, indicating a potential upside of 306.98%. Given Nyxoah's stronger consensus rating and higher probable upside, analysts plainly believe Nyxoah is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

Retractable Technologies beats Nyxoah on 8 of the 15 factors compared between the two stocks.

How does Retractable Technologies compare to electroCore?

Retractable Technologies (NYSE:RVP) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk.

electroCore has a consensus price target of $18.00, suggesting a potential upside of 105.25%. Given electroCore's stronger consensus rating and higher probable upside, analysts plainly believe electroCore is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Retractable Technologies has a beta of 1.22, meaning that its stock price is 22% more volatile than the broader market. Comparatively, electroCore has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market.

Retractable Technologies has higher revenue and earnings than electroCore. electroCore is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.59	-$7.01M	-$0.21	N/A
electroCore	$34.90M	2.08	-$13.97M	-$1.77	N/A

Retractable Technologies has a net margin of -41.11% compared to electroCore's net margin of -44.08%. Retractable Technologies' return on equity of -17.15% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
electroCore	-44.08%	-1,956.38%	-83.30%

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by insiders. Comparatively, 13.8% of electroCore shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Retractable Technologies had 1 more articles in the media than electroCore. MarketBeat recorded 1 mentions for Retractable Technologies and 0 mentions for electroCore. Retractable Technologies' average media sentiment score of 0.00 equaled electroCore'saverage media sentiment score.

Company	Overall Sentiment
Retractable Technologies	Neutral
electroCore	Neutral

Summary

Retractable Technologies beats electroCore on 10 of the 15 factors compared between the two stocks.

How does Retractable Technologies compare to Pulmonx?

Retractable Technologies (NYSE:RVP) and Pulmonx (NASDAQ:LUNG) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

Retractable Technologies has a beta of 1.22, indicating that its share price is 22% more volatile than the broader market. Comparatively, Pulmonx has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market.

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 91.0% of Pulmonx shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by company insiders. Comparatively, 6.8% of Pulmonx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Retractable Technologies had 1 more articles in the media than Pulmonx. MarketBeat recorded 1 mentions for Retractable Technologies and 0 mentions for Pulmonx. Retractable Technologies' average media sentiment score of 0.00 equaled Pulmonx'saverage media sentiment score.

Company	Overall Sentiment
Retractable Technologies	Neutral
Pulmonx	Neutral

Pulmonx has a consensus target price of $5.58, suggesting a potential upside of 301.68%. Given Pulmonx's stronger consensus rating and higher probable upside, analysts plainly believe Pulmonx is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Pulmonx	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Retractable Technologies has a net margin of -41.11% compared to Pulmonx's net margin of -60.09%. Retractable Technologies' return on equity of -17.15% beat Pulmonx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Pulmonx	-60.09%	-92.94%	-39.80%

Retractable Technologies has higher earnings, but lower revenue than Pulmonx. Retractable Technologies is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.59	-$7.01M	-$0.21	N/A
Pulmonx	$90.50M	0.65	-$54M	-$1.30	N/A

Summary

Retractable Technologies beats Pulmonx on 8 of the 15 factors compared between the two stocks.

Get Retractable Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RVP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RVP vs. The Competition

Export

Metric	Retractable Technologies	Surgical & medical instruments Industry	Medical Sector	NYSE Exchange
Market Cap	$21.86M	$46.05M	$7.16B	$23.53B
Dividend Yield	N/A	1.08%	2.66%	3.98%
P/E Ratio	-1.35	20.75	28.02	31.55
Price / Sales	0.59	31.08	540.37	21.06
Price / Cash	48.25	18.86	49.26	25.36
Price / Book	0.22	8.46	10.96	4.81
Net Income	-$7.01M	-$20.01M	$3.57B	$1.07B
7 Day Performance	4.67%	4.17%	2.12%	0.56%
1 Month Performance	6.43%	5.11%	5.25%	4.54%
1 Year Performance	12.15%	-3.58%	33.29%	18.23%

Retractable Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RVP Retractable Technologies	N/A	$0.73 flat	N/A	+12.2%	$21.86M	$37.15M	N/A	240
AGPU Predictive Oncology	0.3774 of 5 stars	$7.22 -4.7%	N/A	N/A	$78.12M	$120K	N/A	30	Gap Up
LNSR LENSAR	1.3532 of 5 stars	$5.84 +2.3%	$10.00 +71.2%	-51.5%	$71.72M	$58.44M	N/A	110	Gap Down
NYXH Nyxoah	2.3641 of 5 stars	$1.78 +5.3%	$7.00 +293.3%	-77.9%	$68.99M	$11.33M	N/A	110
ECOR electroCore	3.0558 of 5 stars	$8.30 -3.9%	$18.00 +116.9%	+45.4%	$68.89M	$32.03M	N/A	50

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:RVP) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Retractable Technologies (RVP) Competitors

RVP vs. AGPU, LNSR, NYXH, ECOR, and LUNG

How does Retractable Technologies compare to Predictive Oncology?

Summary

How does Retractable Technologies compare to LENSAR?

Summary

How does Retractable Technologies compare to Nyxoah?

Summary

How does Retractable Technologies compare to electroCore?

Summary

How does Retractable Technologies compare to Pulmonx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RVP vs. The Competition

Retractable Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Retractable Technologies (RVP) Competitors

RVP vs. AGPU, LNSR, NYXH, ECOR, and LUNG

How does Retractable Technologies compare to Predictive Oncology?

Is AGPU or RVP more profitable?

Which has higher earnings & valuation, AGPU or RVP?

Which has more risk and volatility, AGPU or RVP?

Do analysts prefer AGPU or RVP?

Do institutionals & insiders have more ownership in AGPU or RVP?

Does the media prefer AGPU or RVP?

Summary

How does Retractable Technologies compare to LENSAR?

Which has more risk & volatility, RVP or LNSR?

Does the media prefer RVP or LNSR?

Do analysts prefer RVP or LNSR?

Do institutionals and insiders have more ownership in RVP or LNSR?

Which has preferable valuation & earnings, RVP or LNSR?

Is RVP or LNSR more profitable?

Summary

How does Retractable Technologies compare to Nyxoah?

Which has higher earnings and valuation, RVP or NYXH?

Is RVP or NYXH more profitable?

Do institutionals and insiders hold more shares of RVP or NYXH?

Does the media favor RVP or NYXH?

Which has more volatility and risk, RVP or NYXH?

Do analysts rate RVP or NYXH?

Summary

How does Retractable Technologies compare to electroCore?

Do analysts prefer RVP or ECOR?

Which has more volatility and risk, RVP or ECOR?

Which has preferable valuation and earnings, RVP or ECOR?

Is RVP or ECOR more profitable?

Do institutionals & insiders have more ownership in RVP or ECOR?

Does the media favor RVP or ECOR?

Summary

How does Retractable Technologies compare to Pulmonx?

Which has more volatility and risk, RVP or LUNG?

Do insiders and institutionals hold more shares of RVP or LUNG?

Does the media prefer RVP or LUNG?

Do analysts rate RVP or LUNG?

Is RVP or LUNG more profitable?

Which has stronger valuation & earnings, RVP or LUNG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RVP vs. The Competition

Retractable Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools